Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in Rat-1 cells

Experimental Cell Research

Volumn 290, Issue 2, 2003, Pages 437-446

  Santiskulvong, Chintda ^a   Rozengurt, Enrique ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell cycle activation; Epidermal growth factor receptor; G protein coupled receptors; Ilomastat; Lysophosphatidic acid; MMP

Indexed keywords

BOMBESIN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ILOMASTAT; LIGAND; LYSOPHOSPHATIDIC ACID; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; TYROSINE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; ENZYME ACTIVITY; GENETIC TRANSFECTION; MITOGENESIS; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION;

EID: 0142089835     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00355-0     Document Type: Article

References (57)

1. Offermanns S., Heiler E., Spicher K., Schultz G. Gq and G11 are concurrently activated by bombesin and vasopressin in Swiss 3T3 cells. FEBS Lett. 349:1994;201-204.
2. Hellmich M.R., Battey J.F., Northup J.K. Selective reconstitution of gastrin-releasing peptide receptor with G alpha q. Proc. Natl. Acad. Sci. USA. 94:1997;751-756.
3. Jian X., Sainz E., Clark W.A., Jensen R.T., Battey J.F., Northup J.K. The bombesin receptor subtypes have distinct G protein specificities. J. Biol. Chem. 274:1999;11573-11581.
4. Nanberg E., Rozengurt E. Temporal relationship between inositol polyphosphate formation and increases in cytosolic Ca2+ in quiescent 3T3 cells stimulated by platelet-derived growth factor, bombesin and vasopressin. Embo. J. 7:1988;2741-2747.
5. Erusalimsky J.D., Friedberg I., Rozengurt E. Bombesin, diacylglycerols, and phorbol esters rapidly stimulate the phosphorylation of an Mr = 80,000 protein kinase C substrate in permeabilized 3T3 cells. Effect of guanine nucleotides. J. Biol. Chem. 263:1988;19188-19194.
6. Charlesworth A., Broad S., Rozengurt E. The bombesin/GRP receptor transfected into Rat-1 fibroblasts couples to phospholipase C activation, tyrosine phosphorylation of p125FAK and paxillin and cell proliferation. Oncogene. 12:1996;1337-1345.
7. Daub H., Wallasch C., Lankenau A., Herrlich A., Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. Embo. J. 16:1997;7032-7044.
8. Santiskulvong C., Sinnett-Smith J., Rozengurt E. EGF receptor function is required in late G(1) for cell cycle progression induced by bombesin and bradykinin. Am. J. Physiol. Cell Physiol. 281:2001;C886-C898.
9. Mitchell F.M., Heasley L.E., Qian N.X., Zamarripa J., Johnson G.L. Differential modulation of bombesin-stimulated phospholipase C beta and mitogen-activated protein kinase activity by [D-Arg1,D-Phe5, D-Trp7,9,Leu11]substance P. J. Biol. Chem. 270:1995;8623-8628.
10. Seufferlein T., Withers D.J., Rozengurt E. Reduced requirement of mitogen-activated protein kinase (MAPK) activity for entry into the S phase of the cell cycle in Swiss 3T3 fibroblasts stimulated by bombesin and insulin. J. Biol. Chem. 271:1996;21471-21477.
11. Seckl M.J., Higgins T., Rozengurt E. [D-Argl,D-Trp5,7,9,Leu11] Substance P coordinately and reversibly inhibits bombesin- and vasopressin-induced signal transduction pathways in Swiss 3T3 cell. J. Biol. Chem. 271:1996;29453-29460.
12. Withers D.J., Seufferlein T., Mann D., Garcia B., Jones N., Rozengurt E. Rapamycin dissociates p70(S6K) activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells. J. Biol. Chem. 272:1997;2509-2514.
13. Rozengurt E., Sinnett-Smith J. Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA. 80:1983;2936-2940.
14. Rozengurt E., Sinnett-Smith J. Early signals underlying the induction of the c-fos and c-myc genes in quiescent fibroblasts studies with bombesin and other growth factors . Prog. Nucleic Acid Res. Mol. Biol. 35:1988;261-295.
15. Mann D.J., Higgins T., Jones N.C., Rozengurt E. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells. Oncogene. 14:1997;1759-1766.
16. Slice L.W., Walsh J.H., Rozengurt E. Galpha(13) stimulates Rho-dependent activation of the cyclooxygenase-2 promoter. J. Biol. Chem. 274:1999; 27562-27566.
17. Luttrell L.M., Della Rocca G.J., van Biesen T., Luttrell D.K., Lefkowitz R.J. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272:1997;4637-4644.
18. Maudsley S., Pierce K.L., Zamah A.M., Miller W.E., Ahn S., Daaka Y., Lefkowitz R.J., Luttrell L.M. The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor. J. Biol. Chem. 275:2000;9572-9580.
19. Kim J., Eckhart A.D., Eguchi S., Koch W.J. Beta-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases. J. Biol. Chem. 277:2002;32116-32123.
20. McCole, D.F.K., Stephen, J., Coffey Robert, J., Barrett Kim, E. 2002. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbochol requires extracellular release of transforming growth factor-α. Journal of Biological Chemistry.
21. Umata T., Hirata M., Takahashi T., Ryu F., Shida S., Takahashi Y., Tsuneoka M., Miura Y., Masuda M., Horiguchi Y., Mekada E. A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor. J. Biol. Chem. 276:2001;30475-30482.
22. Pierce K.L., Tohgo A., Ahn S., Field M.E., Luttrell L.M., Lefkowitz R.J. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding . J. Biol. Chem. 276:2001;23155-23160.
23. Kalmes A., Vesti B.R., Daum G., Abraham J.A., Clowes A.W. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ. Res. 87:2000;92-98.
24. Pai R., Soreghan B., Szabo I.L., Pavelka M., Baatar D., Tarnawski A.S. Prostaglandin E2 transactivates EGF receptor a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy . Nat. Med. 8:2002;289-293.
25. Eguchi S., Dempsey P.J., Frank G.D., Motley E.D., Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J. Biol. Chem. 276:2001;7957-7962.
26. Uchiyama-Tanaka Y., Matsubara H., Nozawa Y., Murasawa S., Mori Y., Kosaki A., Maruyama K., Masaki H., Shibasaki Y., Fujiyama S., Nose A., Iba O., Hasagawa T., Tateishi E., Higashiyama S., Iwasaka T. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. Kidney Int. 60:2001;2153-2163.
27. Fujiyama S., Matsubara H., Nozawa Y., Maruyama K., Mori Y., Tsutsumi Y., Masaki H., Uchiyama Y., Koyama Y., Nose A., Iba O., Tateishi E., Ogata N., Jyo N., Higashiyama S., Iwasaka T. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ. Res. 88:2001;22-29.
28. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
29. Tice D.A., Biscardi J.S., Nickles A.L., Parsons S.J. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA. 96:1999;1415-1420.
30. Wu W., Graves L.M., Gill G.N., Parsons S.J., Samet J.M. Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. J. Biol. Chem. 277:2002;24252-24257.
31. Sato K., Sato A., Aoto M., Fukami Y. c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem. Biophys. Res. Commun. 215:1995;1078-1087.
32. Biscardi J.S., Maa M.C., Tice D.A., Cox M.E., Leu T.H., Parsons S.J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 274:1999;8335-8343.
33. Kloth M.T., Laughlin K.K., Biscardi J.S., Boerner J.L., Parsons S.J., Silva C.M. STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor. J. Biol. Chem. 278:2003;1671-1679.
34. Grobelny D., Poncz L., Galardy R.E. Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Biochemistry. 31:1992;7152-7154.
35. Agren M.S., Mirastschijski U., Karlsmark T., Saarialho-Kere U.K. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp. Dermatol. 10:2001;337-348.
36. Hao J.L., Nagano T., Nakamura M., Kumagai N., Mishima H., Nishida T. Effect of galardin on collagen degradation by Pseudomonas aeruginosa. Exp. Eye Res. 69:1999;595-601.
37. Charlesworth A., Rozengurt E. Bombesin and neuromedin B stimulate the activation of p42(mapk) and p74(raf-1) via a protein kinase C-independent pathway in Rat-1 cells. Oncogene. 14:1997;2323-2329.
38. Hordijk P.L., Verlaan I., van Corven E.J., Moolenaar W.H. Protein tyrosine phosphorylation induced by lysophosphatidic acid in Rat-1 fibroblasts. Evidence that phosphorylation of map kinase is mediated by the Gi-p21 ras pathway. J. Biol. Chem. 269:1994;645-651.
39. Contos J.J., Ishii I., Chun J. Lysophosphatidic acid receptors. Mol. Pharmacol. 58:2000;1188-1196.
40. Moolenaar W.H. Lysophosphatidic acid, a multifunctional phospholipid messenger. J. Biol. Chem. 270:1995;12949-12952.
41. Moolenaar W.H., Kranenburg O., Postma F.R., Zondag G.C. Lysophosphatidic acid G-protein signalling and cellular responses . Curr. Opin. Cell Biol. 9:1997;168-173.
42. Hla T., Lee M.J., Ancellin N., Paik J.H., Kluk M.J. Lysophospholipids-receptor revelations. Science. 294:2001;1875-1878.
43. Yang A.H., Ishii I., Chun J. In vivo roles of lysophospholipid receptors revealed by gene targeting studies in mice. Biochim. Biophys. Acta. 1582:2002;197-203.
44. An S., Bleu T., Hallmark O.G., Goetzl E.J. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J. Biol. Chem. 273:1998;7906-7910.
45. Lipson K.E., Pang L., Huber L.J., Chen H., Tsai J.M., Hirth P., Gazit A., Levitzki A., McMahon G. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation. J. Pharmacol. Exp. Ther. 285:1998;844-852.
46. Downward J., Parker P., Waterfield M.D. Autophosphorylation sites on the epidermal growth factor receptor. Nature. 311:1984;483-485.
47. Downward J., Waterfield M.D., Parker P.J. Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J. Biol. Chem. 260:1985;14538-14546.
48. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 379:1996;557-560.
49. Rozengurt E. Neuropeptides as growth factors for normal and cancerous cells. Trends Endocrinol. Metab. 13:2002;128-134.
50. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J. Cell. Physiol. 177:1998;507-517.
51. Kue P.F., Taub J.S., Harrington L.B., Polakiewicz R.D., Ullrich A., Daaka Y. Lysophosphatidic acid-regulated mitogenic ERK signaling in androgen-insensitive prostate cancer PC-3 cells. Int. J. Cancer. 102:2002;572-579.
52. Yan Y., Shirakabe K., Werb Z. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors. J. Cell Biol. 158:2002;221-226.
53. Asakura M., Kitakaze M., Takashima S., Liao Y., Ishikura F., Yoshinaka T., Ohmoto H., Node K., Yoshino K., Ishiguro H., Asanuma H., Sanada S., Matsumura Y., Takeda H., Beppu S., Tada M., Hori M., Higashiyama S. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF metalloproteinase inhibitors as a new therapy . Nat. Med. 8:2002;35-40.
54. Kranenburg O., Verlaan I., Hordijk P.L., Moolenaar W.H. Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. Embo. J. 16:1997;3097-3105.
55. Dikic I., Tokiwa G., Lev S., Courtneidge S.A., Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature. 383:1996;547-550.
56. Gschwind A., Prenzel N., Ullrich A. Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. Cancer Res. 62:2002;6329-6336.
57. Salazar E.P., Hunger-Glaser I., Rozengurt E. Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells. J. Cell Physiol. 194:2003;314-324.